€35.20
1.81%
Paris, Oct 02, 05:35 pm CEST. Closed.
ISIN
FR0004050250
Symbol
NRO

Neurones Target price 2026 - Analyst rating & recommendation

Neurones Classifications & Recommendation

Buy
80%
Hold
20%

Neurones Price Target

Target Price €45.90
Price €35.20
Potential
Number of Estimates 3
3 Analysts have issued a price target Neurones 2027 . The average Neurones target price is €45.90. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 4 Analysts recommend Neurones to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Neurones stock has an average upside potential 2027 of . Most analysts recommend the Neurones stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Million € 857.18 926.17
5.78% 8.05%
EBITDA Margin 10.92% 11.23%
6.92% 2.88%
Net Margin 6.07% 6.10%
6.34% 0.42%

2 Analysts have issued a sales forecast Neurones 2026 . The average Neurones sales estimate is

€926m
unlock
. This is
8.05% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€963m 12.33%
unlock
, the lowest is
€899m 4.84%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 €857m 5.78%
2026
€926m 8.05%
unlock
2027
€982m 6.00%
unlock
2028
€1.0b 5.02%
unlock

2 Analysts have issued an Neurones EBITDA forecast 2026. The average Neurones EBITDA estimate is

€104m
unlock
. This is
11.18% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€108m 15.58%
unlock
, the lowest is
€101m 7.88%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 €93.6m 1.54%
2026
€104m 11.18%
unlock
2027
€115m 10.68%
unlock
2028
€125m 8.77%
unlock

EBITDA Margin

2025 10.92% 6.92%
2026
11.23% 2.88%
unlock
2027
11.73% 4.45%
unlock
2028
12.15% 3.58%
unlock

2 Neurones Analysts have issued a net profit forecast 2026. The average Neurones net profit estimate is

€56.5m
unlock
. This is
8.51% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€58.7m 12.79%
unlock
, the lowest is
€54.8m 5.28%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 €52.1m 0.93%
2026
€56.5m 8.51%
unlock
2027
€63.9m 13.03%
unlock
2028
€71.2m 11.54%
unlock

Net Margin

2025 6.07% 6.34%
2026
6.10% 0.42%
unlock
2027
6.51% 6.72%
unlock
2028
6.91% 6.14%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share € 2.14 2.32
0.93% 8.41%
P/E 15.15
EV/Sales 0.63

2 Analysts have issued a Neurones forecast for earnings per share. The average Neurones EPS is

€2.32
unlock
. This is
8.41% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
€2.42 13.08%
unlock
, the lowest is
€2.25 5.14%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 €2.14 0.93%
2026
€2.32 8.41%
unlock
2027
€2.63 13.36%
unlock
2028
€2.93 11.41%
unlock

P/E ratio

Current 16.45 11.82%
2026
15.15 7.89%
unlock
2027
13.40 11.55%
unlock
2028
12.02 10.30%
unlock

Based on analysts' sales estimates for 2026, the Neurones stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.68 19.05%
2026
0.63 7.81%
unlock
2027
0.59 5.65%
unlock
2028
0.56 4.78%
unlock

P/S ratio

Current 1.02 10.02%
2026
0.94 7.45%
unlock
2027
0.89 5.66%
unlock
2028
0.85 4.77%
unlock

Current Neurones Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
ESN/CIC MARKET SOLUTIONS
Locked
➜
Locked
Locked Sep 10 2026
ESN/CIC MARKET SOLUTIONS
Locked
➜
Locked
Locked Jun 18 2026
ESN/CIC MARKET SOLUTIONS
Locked
➜
Locked
Locked Jun 17 2026
ESN/CIC MARKET SOLUTIONS
Locked
➜
Locked
Locked Feb 12 2026
ESN/CIC MARKET SOLUTIONS
Locked
➜
Locked
Locked Nov 06 2025
ESN/CIC MARKET SOLUTIONS
Locked
➜
Locked
Locked Aug 07 2025
Analyst Rating Date
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
Sep 10 2026
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
Jun 18 2026
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
Jun 17 2026
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
Feb 12 2026
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
Nov 06 2025
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
Aug 07 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today